Navigation Links
FASgen Announces Significant Milestone in Its Cancer Drug Development Program
Date:10/1/2007

BALTIMORE, Oct. 1 /PRNewswire/ -- FASgen's fatty acid synthase inhibitor (FASi) compounds, led by FAS031, have demonstrated efficacy against every solid tumor xenograft cell line tested, in both orthotopic and flank models: 4 lung tumor cell lines (H460; A549; H1975; LX7); two ovarian; breast; and, colon. In many cases the tumors were eradicated entirely. The compounds have been shown in extensive preclinical studies to be remarkably safe and orally available. One compound was safely given to mice twice a day orally for 6 months with no observed adverse side effects except the elimination of the tumors. Other compounds were given to mice in a two year experiment and prevented the onset of tumors in nearly one-third of the mice. That experiment was repeated with a different compound and produced the same result. Several of these results have been recently published and others will shortly be published in leading oncology journals.

FASi is a new mechanism of action for the treatment of cancer. The fatty acid biosynthesis pathway is critical to all living organisms to produce fat and regulate the body's energy. In cancer cells, FASgen researchers over the last 15 years have discovered that the mechanism acts differently. As cancer cells do not produce fat, the fatty acid biosynthesis pathway in the transformed cell acts to regulate the energy source that keeps the cell alive. One critical enzyme in that pathway is FAS. The Company's researchers have discovered that inhibition of FAS kills the cancer cell, a result that has been recently replicated in a number of labs and become the subject of a series of new publications. FASgen has developed a library of FASi compounds and has an extensive body of intellectual property surrounding both the mechanism of action and uses for the compounds, and of course the composition of individual compounds. "This discovery holds out the prospect for a new method of treatment for cancer that is remarkably safe and may dimi
'/>"/>

SOURCE FASgen, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Sygnis Pharma AG announces date for presentation of clinical results
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015 Research and Markets ... of the "Latest Regulations on Pharmaceutical International ... their offering. This is first time ... guidance on international multi-center clinical trials of drugs ... begun to be implemented on March 1, 2015. ...
(Date:5/22/2015)... -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD ) ("Nepstar" ... China based on the number ... Mr. Fuxiang Zhang as the Company,s Chief ... Rebecca Yingnan Zhang has been appointed as Chief ... immediately. Meanwhile, Ms. Zhang resigned from the position as ...
(Date:5/21/2015)... , May 21, 2015 ... has announced the addition of the ... their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The ... and size the world market for Arthroscopy ... identifies trends impacting the market for these ...
Breaking Medicine Technology:2015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 2China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 3Analysing Arthroscopy Devices Markets Worldwide 2014-2020 2Analysing Arthroscopy Devices Markets Worldwide 2014-2020 3
... Reportlinker.com announces that a new ... its catalogue: Ophthalmic ... and Cataract Surgery Devices, Minimally Invasive ... the Ophthalmic Surgery Market ...
... NEW YORK, Oct. 24, 2011 Phreesia, the patient ... cash flow for medical practices nationwide with its electronic ... which it saves time for practices is by automating ... manual work and guaranteeing accurate billing by confirming coverage ...
Cached Medicine Technology:Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market 2Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market 3Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market 4Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market 5Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market 6Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market 7Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market 8Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market 9Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market 10Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market 11Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market 12Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market 13Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market 14Phreesia Continues to Enhance its Market-Leading Eligibility and Benefits Verification Process for Medical Practices 2
(Date:5/26/2015)... Janesville, WI (PRWEB) May 26, 2015 ... - Schrader is responsible for using her quality ... Care ’s day-to-day operations. Denise also provides leadership and ... of Mercy Hospice Care, Mercy Home Health Care and ... of experience in health care administration with the last ...
(Date:5/26/2015)... May 26, 2015 U.S. Food and ... the United States are extensive and can be difficult ... that helps medical device companies comply with FDA regulations, ... device companies navigate FDA requirements. , 1. Start ... United States can be a lengthy process depending on ...
(Date:5/26/2015)... 2015 Beginning this fall, Boston University ... online Master of Social Work (MSW) program . Already ... Charles River Campus, the online option will be offered ... Standing option is open to applicants holding an undergraduate ... Work Education. Students entering the program will be granted ...
(Date:5/26/2015)... Dearborn Ear, Nose & Throat in Dearborn, ... new and improved website to better showcase their Detroit ... Ear, Nose & Throat’s new website utilizes an innovative ... website seamlessly on any desktop computer, tablet or mobile ... Ear, Nose & Throat website include an innovative ...
(Date:5/25/2015)... Dallas, TX (PRWEB) May 26, 2015 ... H1 2015” provides comprehensive information on the therapeutic ... pipelines by identifying new targets and MOAs to ... H1 2015 pipeline review of Liver Failure with ... across 65 pages is available at http://www.rnrmarketresearch.com/liver-failure-pipeline-review-h1-2015-market-report.html ...
Breaking Medicine News(10 mins):Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 2Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 3Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 4Health News:Boston University to Offer Online Master of Social Work Advanced Standing Option 2Health News:Boston University to Offer Online Master of Social Work Advanced Standing Option 3Health News:Dearborn Ear, Nose & Throat Launches ‘Responsive Design’ Website 2Health News:Liver Failure Pipeline Assessment and Key Players Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Liver Failure Pipeline Assessment and Key Players Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Liver Failure Pipeline Assessment and Key Players Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4
... in 26 best-selling alcoholic beverages , , MONDAY, June 30 (HealthDay ... an ice cold beer, right? , And the just reward ... -- how about a slightly chilled chardonnay? , Well, before ... might want to consult a new report, called Alcohol ...
... enzymes do damage in both conditions, study finds , , MONDAY, ... malfunction may explain the development of high blood pressure, diabetes ... known as proteases roam the body, clipping off working segments ... do its job, according to a report in the June ...
... Inc.,(NYSE: RBN ) issued a correction to its ... scheduled today, June 30 at 11:00 a.m. EDT.,Participants should ... the call can be accessed by dialing,888-286-8010 (U.S./Canada) or ... Inc. is a leading supplier of supplier of engineered,equipment ...
... To further growth of the,organization and consolidate and ... has made several key executive,appointments, effective July 1, ... executive officer, becomes chairman,of Broadspire., -- Kenneth ... will,assume the responsibilities of chief executive officer, reporting ...
... New support surface products to be included as part of ... and ... preventing pressure ulcers, MUNDELEIN, Ill., June ... therapeutic pressure redistribution,mattresses, operating room table pads and stretcher pads ...
... of Technology to ... Community Physicians, ... provider of clinical software and information,solutions that physicians use to ... selected the Allscripts,Electronic Health Record (EHR) for 138 of its ...
Cached Medicine News:Health News:Want to Know the Calorie Content of Your Favorite Drink? 2Health News:Want to Know the Calorie Content of Your Favorite Drink? 3Health News:New Molecular Trigger Described for Hypertension, Diabetes 2Health News:New Molecular Trigger Described for Hypertension, Diabetes 3Health News:Broadspire Announces Key Leadership Appointments 2Health News:Broadspire Announces Key Leadership Appointments 3Health News:Medline Announces Advanced Line of Therapeutic Mattresses, Operating Room Table Pads and Stretcher Pads 2Health News:Medline Announces Advanced Line of Therapeutic Mattresses, Operating Room Table Pads and Stretcher Pads 3Health News:East Jefferson General Hospital Selects Allscripts Electronic Health Record, Offers Free Electronic Prescribing for Affiliated New Orleans-Area Physicians 2Health News:East Jefferson General Hospital Selects Allscripts Electronic Health Record, Offers Free Electronic Prescribing for Affiliated New Orleans-Area Physicians 3Health News:East Jefferson General Hospital Selects Allscripts Electronic Health Record, Offers Free Electronic Prescribing for Affiliated New Orleans-Area Physicians 4
Ballard trach care HMES and filters, tv1000, HME...
Indications For Usage: ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hours...
... helps provide protection to the exposed airway of ... lightweight making it ideal for active young children ... of heat and moisture recovery, it ensures patient ... and filters have ISO standard tapered ends to ...
For use with: , pulmonary function testing , nebulizer compressors , humidifiers , concentrators , proximal pressure lines ...
Medicine Products: